BBVA (BBVA.BME) AI OPINIONS & ADVISOR ANALYSIS

The bull case activates if Mexican credit quality holds while the peso stabilises through the USMCA review. Cost of risk stays inside guidance, allowing management to convert the full EUR 12bn excess-capital tranche into buybacks rather than provisions; the share count shrinks faster than modelled, EPS compounds in the mid-teens, and the 2.3x multiple is validated rather than compressed. Add a disciplined acquisition near book value and BBVA becomes the structurally re-rated European bank, delivering equity-like returns plus a growing dividend.

The bear case begins where volume growth stops disguising margin decay. Loans grew 17.7% while impairments rose 35%; if those vintages sour as euro-area rates bite with a lag, cost of risk breaches 200bp, the excess-capital tranche is consumed by provisions and buybacks pause. A simultaneous peso devaluation on trade rupture would compress translated earnings and capital together, and a bank earning 14% ROTE does not command 2.3x tangible book. The de-rating would be swift and self-reinforcing.

The settled belief: BBVA is now a 22% ROTE distribution machine liberated from the Sabadell distraction, and the premium multiple is deserved. The stock trades above most sell-side targets after a 52-week high and a 23% year-to-date advance [14][15]. The anchoring bias is extrapolation - treating H1 2026's 17.7% loan growth and record profit as the new baseline rather than a late-cycle peak.

The crowd modestly overestimates what these shares are worth - not because the franchise is weak, but because the re-rating has already been paid for. At roughly 2.3x tangible book against 0.6-1.0x in 2020-2024, a Gordon-growth check with 22% ROTE, 12% cost of equity and 4% growth justifies about 2.25x: fair, not cheap. The overlooked evidence is provisions rising 35% year-on-year alongside the loan surge [11], meaning the ROTE being capitalised into perpetuity is a cyclical high, not a structural constant.

Watch the Q3 2026 print in late October and the FY2026 guidance that follows. The first observable sign of repricing is cost of risk guidance drifting above 150bp group-wide while loan growth decelerates toward the plan's 5% - the moment volume stops disguising margin normalisation and the multiple, not the earnings, adjusts.